Proactive Investors - Run By Investors For Investors

Maverix Metals CEO releases 2019 guidance and talks successful 2018

Maverix Metals (CVE:MMX) CEO Dan O'Flaherty sat down with Steve Darling from Proactive Investors Vancouver to discuss the company and their performance in 2018. O'Flaherty discussed the impressive amount of deals they did and one deal in particular.

O'Flaherty also discussed their 2019 guidance and what shareholders can expect moving forward.

 
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »
View full MMX profile View Profile

Maverix Metals Inc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use